Total Payments
$1,174
2024 Payments
$345.58
Companies
10
Transactions
39
Medicare Patients
331
Medicare Billing
$30,992
Payment Breakdown by Category
Food & Beverage$1,166 (99.3%)
Education$8.45 (0.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,166 | 38 | 99.3% |
| Education | $8.45 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $391.21 | 18 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $268.67 | 5 | $0 (2024) |
| Galderma Laboratories, L.P. | $225.01 | 2 | $0 (2021) |
| Incyte Corporation | $75.90 | 4 | $0 (2024) |
| GENZYME CORPORATION | $58.64 | 3 | $0 (2024) |
| VYNE Pharmaceuticals Inc. | $50.85 | 1 | $0 (2020) |
| Lilly USA, LLC | $38.47 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $26.48 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $25.86 | 1 | $0 (2024) |
| Amgen Inc. | $13.23 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $345.58 | 23 | ABBVIE INC. ($178.51) |
| 2023 | $51.25 | 3 | Incyte Corporation ($20.98) |
| 2022 | $76.47 | 1 | ABBVIE INC. ($76.47) |
| 2021 | $350.49 | 6 | Galderma Laboratories, L.P. ($112.07) |
| 2020 | $50.85 | 1 | VYNE Pharmaceuticals Inc. ($50.85) |
| 2019 | $299.68 | 5 | Regeneron Healthcare Solutions, Inc. ($148.83) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Immunology | ||||||
| 06/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: IMMUNOLOGY | ||||||
| 06/14/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Immunology | ||||||
| 06/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: IMMUNOLOGY | ||||||
| 06/05/2024 | ABBVIE INC. | HUMIRA (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: IMMUNOLOGY | ||||||
| 05/29/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Inflammation | ||||||
| 05/28/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: IMMUNOLOGY | ||||||
| 05/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.60 | General |
| Category: IMMUNOLOGY | ||||||
| 05/08/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $17.48 | General |
| Category: Dermatology | ||||||
| 05/01/2024 | ABBVIE INC. | HUMIRA (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.26 | General |
| Category: IMMUNOLOGY | ||||||
| 04/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.81 | General |
| Category: IMMUNOLOGY | ||||||
| 03/28/2024 | ABBVIE INC. | — | Education | In-kind items and services | $8.45 | General |
| 03/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/27/2024 | ABBVIE INC. | HUMIRA (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: IMMUNOLOGY | ||||||
| 03/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Immunology | ||||||
| 03/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: IMMUNOLOGY | ||||||
| 03/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.67 | General |
| Category: IMMUNOLOGY | ||||||
| 02/28/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: Dermatology | ||||||
| 02/21/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $13.33 | General |
| Category: Dermatology | ||||||
| 02/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.16 | General |
| Category: Immunology | ||||||
| 01/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: IMMUNOLOGY | ||||||
| 01/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: IMMUNOLOGY | ||||||
| 01/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.28 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.32 | General |
| Category: Immunology | ||||||
| 11/30/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.98 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 331 | 475 | $97,336 | $30,992 |
Total Patients
331
Total Services
475
Medicare Billing
$30,992
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 13 | 14 | $21,662 | $6,743 | 31.1% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 12 | 20 | $18,860 | $6,553 | 34.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 50 | 50 | $12,813 | $4,141 | 32.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 36 | 36 | $8,550 | $2,631 | 30.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 33 | $6,831 | $2,322 | 34.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 29 | 29 | $7,613 | $2,319 | 30.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 57 | 57 | $8,835 | $2,207 | 25.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 39 | 39 | $6,503 | $2,176 | 33.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 23 | $2,973 | $981.20 | 33.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 40 | 174 | $2,697 | $918.44 | 34.1% |
About Robert Simonds
Robert Simonds is a MOHS-Micrographic Surgery healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2018. The National Provider Identifier (NPI) number assigned to this provider is 1952806317.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Simonds has received a total of $1,174 in payments from pharmaceutical and medical device companies, with $345.58 received in 2024. These payments were reported across 39 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,166).
As a Medicare-enrolled provider, Simonds has provided services to 331 Medicare beneficiaries, totaling 475 services with total Medicare billing of $30,992. Data is available for 1 year (2023–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Dermatology
- Location Cleveland, OH
- Active Since 03/28/2018
- Last Updated 08/02/2023
- Taxonomy Code 207ND0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1952806317
Products in Payments
- ORACEA (Drug) $225.01
- LIBTAYO (Biological) $196.09
- SKYRIZI (Biological) $128.12
- DUPIXENT (Biological) $109.67
- RINVOQ (Biological) $82.66
- OPZELURA (Drug) $75.90
- HUMIRA (Biological) $52.70
- AMZEEQ (Drug) $50.85
- TALTZ (Drug) $38.47
- Sotyktu (Drug) $26.48
- COSENTYX (Drug) $25.86
- LIBTAYO (Drug) $21.55
- Humira (Biological) $16.36
- Otezla (Drug) $13.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.